Insteel (IIIN) CEO equity awards — 21,355 options and 7,819 RSUs detailed
Rhea-AI Filing Summary
WOLTZ H O III, who serves as Chairman, President and CEO of Insteel Industries, Inc. (IIIN), reported equity awards on 08/11/2025. He was granted an option to buy 21,355 shares at an exercise price of $35.97, exercisable beginning 08/11/2026 and expiring 08/11/2035, with options vesting one-third annually starting one year from the grant. He also received 7,819 restricted stock units that convert one-for-one into common stock and will vest on 08/11/2028. Both holdings are reported as direct beneficial ownership following the transactions.
Positive
- Equity awards granted: CEO received an option for 21,355 shares and 7,819 restricted stock units (RSUs).
- Clear vesting terms: Option vests one‑third annually beginning one year after grant; RSUs vest on 08/11/2028.
Negative
- Long vesting horizon: RSUs do not vest until 08/11/2028, delaying potential alignment with short‑term performance.
- Potential dilution not disclosed: The filing lists granted amounts but provides no context on total outstanding shares or plan limits.
Insights
TL;DR: CEO received time‑based equity awards with multi-year vesting, disclosed as direct ownership.
The Form 4 shows customary compensation grants to the company’s CEO: a stock option for 21,355 shares at $35.97 and 7,819 restricted stock units. The option becomes exercisable one year after grant and vests in three annual installments; the RSUs vest on a single date in 2028. These are direct holdings reported under Section 16 and reflect equity compensation governed by the issuer’s plan; the filing provides vesting schedules and conversion mechanics but no information on aggregate outstanding dilution or prior holdings beyond the post‑transaction amounts disclosed.
TL;DR: Grants combine long‑dated options and delayed RSU vesting, aligning pay delivery over several years.
The reported awards pair an 10‑year option (expires 08/11/2035) with a three‑year vesting cadence for the option and a fixed RSU vest date (08/11/2028). The exercise price is stated as $35.97. From a pay‑structure perspective, the mix of options and RSUs staggers potential equity realization and ties value to sustained share performance and tenure. The filing is limited to the grant details and does not disclose plan limits, total dilution, or past grants that would contextualize materiality.